Healthcare Giants or Medical Innovators? XLV and PINK Are Built for Different Investors.
Key takeaways
- Investors evaluating the healthcare sector could choose between the stability of established medical giants and the high-growth potential of cutting-edge innovation.
- Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns.
- The State Street fund is more affordable than the Simplify fund, carrying an expense ratio of just 0.08% compared to 0.51%.
XLV The State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) provides low-cost, passive exposure to established healthcare giants, while the Simplify Health Care ETF (NYSEMKT:PINK) offers an active strategy targeting medical breakthroughs.
Investors evaluating the healthcare sector could choose between the stability of established medical giants and the high-growth potential of cutting-edge innovation. While both funds operate within the medical sector, they differ significantly in their investment philosophies. The State Street fund tracks a well-known index, whereas the Simplify fund employs active management led by Michael Taylor, who utilizes over 20 years of experience to navigate the complexities of the biotech and medtech industries.
Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.